KLRK1 and acute myeloid leukemia: Downregulation of NKG2D expression was measured by flow cytometry using exosomes isolated from plasma of four AML patients at diagnosis or from supernatants of leukemia cell lines, Kasumi-1 or ML-2 (Fig. 3c; Table 1).